Deutsche Bank’s Cardiff Oncology CRDF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $70.9K | Sell |
43,784
-104
| -0.2% | -$214 | ﹤0.01% | 3377 |
|
|
2025
Q4 | $123K | Buy |
43,888
+43,140
| +5,767% | +$100K | ﹤0.01% | 3228 |
|
|
2025
Q3 | $1.54K | Sell |
748
-39,579
| -98% | -$109K | ﹤0.01% | 3568 |
|
|
2025
Q2 | $127K | Sell |
40,327
-9,109
| -18% | -$27.8K | ﹤0.01% | 3172 |
|
|
2025
Q1 | $155K | Sell |
49,436
-130
| -0.3% | -$514 | ﹤0.01% | 3064 |
|
|
2024
Q4 | $215K | Buy |
+49,566
| New | +$155K | ﹤0.01% | 3069 |
|
|
2023
Q1 | – | Sell |
-224,057
| Closed | -$314K | – | 3925 |
|
|
2022
Q4 | $314K | Hold |
224,057
| – | – | ﹤0.01% | 2718 |
|
|
2022
Q3 | $345K | Hold |
224,057
| – | – | ﹤0.01% | 2611 |
|
|
2022
Q2 | $493K | Sell |
224,057
-20,681
| -8% | -$34.6K | ﹤0.01% | 2607 |
|
|
2022
Q1 | $607K | Sell |
244,738
-2,458
| -1% | -$8.69K | ﹤0.01% | 2636 |
|
|
2021
Q4 | $1.49M | Buy |
247,196
+1,232
| +0.5% | +$7.34K | ﹤0.01% | 2187 |
|
|
2021
Q3 | $1.64M | Sell |
245,964
-75,658
| -24% | -$475K | ﹤0.01% | 2260 |
|
|
2021
Q2 | $2.14M | Buy |
321,622
+56,028
| +21% | +$475K | ﹤0.01% | 2157 |
|
|
2021
Q1 | $2.46M | Buy |
265,594
+249,300
| +1,530% | +$3.03M | ﹤0.01% | 2022 |
|
|
2020
Q4 | $293K | Buy |
+16,294
| New | +$286K | ﹤0.01% | 3240 |
|
|
2019
Q3 | – | Sell |
-100
| Closed | – | – | 4939 |
|
|
2019
Q2 | $0 | Buy |
+100
| New | +$321 | ﹤0.01% | 5310 |
|
|
2018
Q3 | – | Sell |
-27
| Closed | – | – | 5380 |
|
|
2018
Q2 | $0 | Hold |
27
| – | – | ﹤0.01% | 5441 |
|
|
2018
Q1 | $0 | Buy |
27
+22
| +440% | +$542 | ﹤0.01% | 5426 |
|
|
2017
Q4 | $0 | Hold |
5
| – | – | ﹤0.01% | 5008 |
|
|
2017
Q3 | $0 | Hold |
5
| – | – | ﹤0.01% | 4904 |
|
|
2017
Q2 | $0 | Sell |
5
-369
| -99% | -$23.8K | ﹤0.01% | 4956 |
|
|
2017
Q1 | $29K | Buy |
374
+130
| +53% | +$17.7K | ﹤0.01% | 4394 |
|
|
2016
Q4 | $36K | Buy |
244
+76
| +45% | +$17.7K | ﹤0.01% | 4433 |
|
|
2016
Q3 | $54K | Buy |
168
+6
| +4% | +$2.19K | ﹤0.01% | 4189 |
|
|
2016
Q2 | $50K | Buy |
162
+16
| +11% | +$5.51K | ﹤0.01% | 4410 |
|
|
2016
Q1 | $48K | Sell |
146
-65
| -31% | -$22.1K | ﹤0.01% | 4332 |
|
|
2015
Q4 | $80K | Sell |
211
-353
| -63% | -$138K | ﹤0.01% | 4164 |
|
|
2015
Q3 | $229K | Sell |
564
-298
| -35% | -$156K | ﹤0.01% | 3737 |
|
|
2015
Q2 | $629K | Buy |
862
+834
| +2,979% | +$592K | ﹤0.01% | 3269 |
|
|
2015
Q1 | $13K | Hold |
28
| – | – | ﹤0.01% | 4757 |
|
|
2014
Q4 | $8K | Hold |
28
| – | – | ﹤0.01% | 5763 |
|
|
2014
Q3 | $9K | Buy |
+28
| New | +$8.38K | ﹤0.01% | 5409 |
|
Other funds holding CRDF
VCM
LCM
P
ACA
FLPIM
Deutsche Bank's CRDF Position: Q1 2026 in Review
Deutsche Bank reduced its Cardiff Oncology (CRDF) stake by 0.24% in Q1 2026, selling an estimated $214 and leaving 43,784 shares worth $70.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3377.
Deutsche Bank first reported a position in CRDF in Q3 2014 and has held it in 32 quarters since. The position peaked at $2.46M in Q1 2021. 116 funds tracked by Wall St. Rank hold CRDF as of Q1 2026.
- Deutsche Bank held 43,784 shares of Cardiff Oncology worth $70.9K as of Q1 2026.
- Deutsche Bank sold 104 Cardiff Oncology shares in Q1 2026, an estimated $214.
- Cardiff Oncology made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #3377 holding.
- Deutsche Bank first reported a position in Cardiff Oncology in Q3 2014 and has held it in 32 quarters since.
- Deutsche Bank's Cardiff Oncology position peaked at $2.46M in Q1 2021.
- 116 funds tracked by Wall St. Rank held Cardiff Oncology as of Q1 2026.
Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.